rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2003-3-4
|
pubmed:abstractText |
Glycoglycerolipid analogues lacking the glycerol backbone were prepared through a lipase catalyzed transesterification of beta-D-galactosylethylene glycol. The inhibitory effect of the resultant isomeric hexanoates at the primary alcoholic positions, beta-D-galactosylethylene glycol itself and nonyl beta-D-galactopyranoside, was tested on Epstein-Barr virus early antigen (EBV-EA) activation in Raji cells promoted by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), as a primary screening test for inhibitors of tumor promotion. All the compounds assayed were found to be less active than the reference 2-O-beta-D-galactopyranosylglycerol derivatives, of which they are simplified models, indicating that the anti-tumor-promoting activity is very closely related to the presence of a free hydroxymethylene group on the glycerol-like aglycone moiety.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0968-0896
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
909-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12614876-Anticarcinogenic Agents,
pubmed-meshheading:12614876-Antigens, Viral,
pubmed-meshheading:12614876-Candida,
pubmed-meshheading:12614876-Carcinogens,
pubmed-meshheading:12614876-Drug Screening Assays, Antitumor,
pubmed-meshheading:12614876-Glycerol,
pubmed-meshheading:12614876-Glycolipids,
pubmed-meshheading:12614876-Humans,
pubmed-meshheading:12614876-Lipase,
pubmed-meshheading:12614876-Pseudomonas,
pubmed-meshheading:12614876-Tetradecanoylphorbol Acetate
|
pubmed:year |
2003
|
pubmed:articleTitle |
Synthesis and anti-tumor-promoting activity of glycoglycerolipid analogues lacking the glycerol backbone.
|
pubmed:affiliation |
Dipartimento di Chimica, Biochimica e Biotecnologie per la Medicina, Università di Milano, Via Saldini 50, 20133 Milan, Italy. diego.colombo@unimi.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|